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Background. A functional interplay between BAs and microbial composition in gut is a well-documented phenomenon. In
bile, this phenomenon is far less studied, and with this report, we describe the interactions between the BAs and
microbiota in this complex biological matrix. Methodology. Thirty-seven gallstone disease patients of which twenty-one
with Opisthorchis felineus infection were enrolled in the study. The bile samples were obtained during laparoscopic
cholecystectomy for gallstone disease operative treatment. Common bile acid composition was measured by LC-MS/MS.
Gallbladder microbiota were previously analyzed with 16S rRNA gene sequencing on Illumina MiSeq platform. The associations
between bile acid composition and microbiota were analyzed. Results. Bile acid signature and Opisthorchis felineus infection
status exert influence on beta-diversity of bile microbial community. Direct correlations were found between taurocholic acid,
taurochenodeoxycholic acid concentrations, and alpha-diversity of bile microbiota. Taurocholic acid and taurochenodeoxycholic
acid both show positive associations with the presence of Chitinophagaceae family, Microbacterium and Lutibacterium genera,
and Prevotella intermedia. Also, direct associations were identified for taurocholic acid concentration and the presence of
Actinomycetales and Bacteroidales orders, Lautropia genus, Jeotgalicoccus psychrophilus, and Haemophilus parainfluenzae as
well as for taurochenodeoxycholic acid and Acetobacteraceae family and Sphingomonas genus. There were no differences in bile
acid concentrations between O. felineus-infected and noninfected patients. Conclusions/Significance. Associations between
diversity, taxonomic profile of bile microbiota, and bile acid levels were evidenced in patients with cholelithiasis. Increase of
taurochenodeoxycholic acid and taurocholic acid concentration correlates with bile microbiota alpha-diversity and appearance
of opportunistic pathogens.
1. Introduction
Liver bile ducts and gallbladder have some of the most
unexplored biomes in the human body due to the inva-
siveness of their exploration. For a long time, bile of the
healthy organisms was considered sterile [1], but recently, it
has been shown that healthy pigs have a native bile duct
microbiota [2], and 16S rRNA gene profiling has confirmed
the presence of bacterial amplicons belonging to Firmicutes,
Bacteroidetes, and Actinobacteria phyla in the human intact
gallbladder bile [3, 4]. Several bile-related disorders can
modify the microbiota of the biliary tract and the gallbladder.
It was shown that the abundance of Bacteroidaceae, Prevotel-
laceae, Porphyromonadaceae, and Veillonellaceae families
was increased in the bile of patients with cholelithiasis [3].
The primary sclerosing cholangitis leads to a reduction of
the microbial diversity with alteration of Pasteurellaceae,
Staphylococcaceae, and Xanthomonadaceae abundances,
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and Streptococcus abundance shows a strong positive cor-
relation with the disease severity and the number of previ-
ous cholangiography examinations [5]. Liver fluke infection
with O. viverrini also resulted in an alteration of taxonomic
composition and an increase of alpha-diversity in the bile
microbiome in animal model [6]. Human-based study of
gallbladder microbiota in O. felineus infection confirmed
the fact of fluke-induced shifts in the bile microbial
community structure and the introduction of taxons unde-
tectable in microbiota of noninfected individuals [7].
Interaction of the gut microbiota with bile acid metab-
olism is well known. It was reported that the pathology-
driven shift in the microbiota diversity may lead to the
alterations of the bile acid (BA) repertoire [8]. Alternatively,
the BAs themselves can affect gut microbiota community
directly (antimicrobial and progerminative actions) and indi-
rectly via farnesoid X receptor activation [9]. The interplay
between microbiota and BAs in the bile is much less studied.
Current knowledge is mainly limited to the important role of
the different levels of BA or its glycine and/or taurine conju-
gates for the biliary diseases [10, 11]. Liang et al. provided
evidence for an association between BA levels and abundance
of bacteria from Bilophila genus in the supraduodenal segment
of common bile duct in cholangiolithiasis patients [12].
In our previous work, we characterized the gallbladder
microbiota of patients with gallstone disease [7]. Here, to cor-
roborate additional evidence of the bile pathology-driving
changes in gallbladder flora, we are aiming to explore the
possible links between the most abundant BAs and microbi-
ota on the background of cholelithiasis.
2. Materials and Methods
2.1. Study Population. The study was approved by the Ethics
Committee of the Siberian State Medical University. Thirty-
seven participants (11 males and 26 females) with age
ranging from 40 to 61 and diagnosed with gallstone disease
were enrolled in the study. Twenty-one of the patients were
diagnosed with O. felineus infection. Clinical characteristics
of the patients are listed in Supplementary Table 1. The
bile samples from patients were obtained during surgical
gallbladder removal (laparoscopic cholecystectomy). During
the surgical intervention, 5–10 milliliters of gallbladder bile
were aspirated under sterile conditions and immediately
delivered to the laboratory. Two milliliters of bile was
clarified by centrifugation (10, 000 g, 10min, 4°C), the
pellet was stored at -80°C for bile microbiota analysis, and
the supernatant was stored at -80°C for bile acid analysis.
2.2. Bile Acid Analysis. LC-MS/MS analysis was applied for
the quantification of the following ten of the most common
bile acids (BAs) in a complex matrix such as the bile: cholic
acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid
(DCA), ursodeoxycholic acid (UDCA), taurocholic acid
(TCA), taurochenodeoxycholic acid (TCDCA), taurolitho-
cholic acid (TLCA), glycocholic acid (GCA), glycocheno-
deoxycholic acid (GCDCA), and glycodeoxycholic acid
(GDCA) as described previously [13]. A detailed description
of the analytical procedure is presented in the supplementary
material. Briefly, 10 BA reference standards were dissolved in
methanol to prepare individual stock solutions. 50μl of each
bile sample from all the patients was collected, mixed to
obtain a pool. Bile was 2000-fold diluted using deionized
water and incubated with 100mg/ml activated charcoal for
2 h to strip this matrix of endogenous BAs. The calibration
curves were prepared in bile striped from endogenous BAs
by treatment with activated charcoal.
For bile samples, C18 solid-phase extraction (SPE)
cartridges were used for sample clean-up. Bile samples were
diluted 2000-fold with LC-MS grade water; 100μl of diluted
bile samples was spiked with 10μl internal standards,
vortexed, and loaded onto preconditioned SPE cartridges.
Loaded cartridges were washed with 2ml H2O and eluted
with 4ml MeOH. The eluate was evaporated under vacuum
and reconstituted in 100μl of 50% MeOH. The analysis was
carried out by LC-MS/MS using a column in reverse phase
in a gradient elution with mobile phases consisted of 0.01%
acetic acid in water (mobile phase A) and 0.01% acetic
acid in methanol (mobile phase B), at a total flow rate
of 0.5ml/min, in negative ionization mode.
2.3. Bile Microbiota Analysis. Gallbladder bile sample micro-
biota for each of the patient were previously analyzed and
described with 16S rRNA gene sequencing on Illumina
MiSeq machine [7]. Raw 16S rRNA gene reads data are
available on European Nucleotide Archive, accession number
PRJEB12755, http://www.ebi.ac.uk/ena/data/view/PRJEB12755.
Sequencing results were analyzed as described in Saltykova
et al. [7]. Briefly, reads analysis was implemented in QIIME
1.9.0 [14]. After demultiplexing, forward and reverse reads
were joined via SeqPrep algorithm; then, reads quality was
checked in sliding window with default parameters. Bases
with Phred quality score less than 19 were truncated and
reads to short after truncation were omitted. The opera-
tional taxonomic unit (OTU) picking consisted in usage
of the open reference picking strategy by the UCLUST
method [15]. Chimera-checked 97% similarity Greengenes
taxonomy v13.5 [16] was used as the reference base for
taxonomic assignment. All OTUs present only in reagent
controls were subtracted from experimental samples to
eliminate contamination.
Alpha-diversity or microbial community taxonomic
richness was calculated in QIIME using Chao1, observed
OTUs, Shannon, and Simpson indices at depth of 200
sequences per sample. For further analysis, we included
samples with at least 200 sequences based on sequencing
depth and rarefaction curve estimation. All OTUs observed
in less than 3 samples were excluded, and microbial data
was normalized with CSS algorithm [17]. Distances between
samples in unweighted UniFrac metrics for estimation of
pairwise dissimilarity between communities (beta-diversity)
were calculated in QIIME.
2.4. Statistical Analysis. Statistical analysis was implemented
in R 3.5.1 version [18]. To examine differences in BA concen-
trations between infected and noninfected patients, Mann-
Whitney-Wilcoxon test was used. FDR-corrected Spearman
rank correlation (psych package [19]) was used to define
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a linkage between taxonomic richness and BA levels.
Contribution of BA concentrations to gallbladder flora
beta-diversity was estimated with permutational multivari-
ate analysis of variance (algorithm adonis of vegan pack-
age [20]) with 9999 permutations in the model which
includes distance matrix as outcome and transformed
metabolite concentrations along with invasion status and
gender as predictors. For this analysis, BA concentrations
were transformed with nonmetric multidimensional scaling
(NMDS) in Euclidean metrics to one vector that represents
the value of the first principle coordinate. NMDS was used
for dimension reduction of microbial data to produce scatter-
plot for visualization of beta-diversity. All metabolites linked
with microbiota diversity were enrolled in further analysis.
Associations between microbial phylotypes and BA levels
were defined by linear regression in model with BA concen-
trations as outcome, OTU presence data as a predictor, and
age, gender, and body mass index as covariates. In case of
multiple hypotheses testing, p values were corrected with
FDR method. Visualization was made in ggplot2 [21] and
corrplot [22] packages.
3. Results
3.1. Gallbladder Bile Acid Signature. Table 1 summarizes the
results of the LC-MS-based quantification of the ten most
abundant bile acids. The optimized and validated method
was applied for the analysis of selected bile acids in the bile
of 37 participants. Primary BAs and its conjugates have about
78% of abundance in the gallbladder. The most abundant of
measured BAs in human gallbladder with the concentrations
more than 1000ng/ml in all groups were GCA (31.9%),
GCDCA (23.6%), GDCA (18.7%), and TCDCA (16.9%).
Other measured BAs amount to 9% of total concentration.
The high abundance of GCA, GCDCA, and TCDCA in the
total bile composition of patients with cholelithiasis was
consistent with the results reported for patients with benign
biliary disease [23].
3.2. Bile Acids and Microbial Community Structure. As it was
shown recently, O. felineus infection affects beta-diversity of
the bile flora [7]. Thus, to identify the input of BAs on the
microbiota variance, we included in the analysis the status
of the infection with the liver fluke. Pairwise dissimilarity
between communities (beta-diversity) was computed in
unweighted UniFrac metric. BA concentrations were trans-
formed with NMDS to one coordinate vector which was
added in adonis model along with O. felineus infection status
and participants’ gender as covariate (Figure 1). It results in
5.8% of microbial data variance explained with O. felineus
infection status (p = 0:006) and 4.6% of variance explained
with BAs (p = 0:025). Gender does not provide significant
input in microbial community structure (p = 0:156).
Taxonomic richness (alpha-diversity) of gallbladder
microbiota was estimated at a depth of 200 sequences with
richness metrics of Chao1, PD whole tree, Shannon, Simp-
son, and a number of observed OTUs. To identify possible
associations between microbiome alpha-diversity and BA
levels, Spearman correlation was used. Significant direct
correlations were found between microbial community rich-
ness measured with Chao1 and phylogenetically driving PD
whole tree indices as well as a number of observed OTUs
and the levels of taurine-conjugated forms of primary BAs
(TCA and TCDCA, Figure 2).
3.3. Associations in the System of Gallbladder Microbiota and
Bile Acids. Thus, considering the results presented in
Figure 2, TCA and TCDCA were used to test the correlations
between BA concentration and appearance of bacterial OTUs
in bile. For the analysis, bacterial counts were recomputed to
the presence/absence of Boolean values. Linear regression
revealed associations of bacterial OTU presence and levels
of TCA and TCDCA in gallbladder bile. TCA concentration
was directly linked with the presence of Actinomycetales
and Bacteroidales orders in gallbladder flora. Chitinopha-
gaceae family, Lautropia, Lutibacterium, Microbacterium,
and uncultivated 1-68 genus of (Tissierellaceae) family, and
Jeotgalicoccus psychrophilus, Prevotella intermedia, and
Haemophilus parainfluenzae species also were linked with
TCA concentration (Table 2, S1 Fig). TCDCA concentration
shows positive associations with the presence of OTUs
belonging to Chitinophagaceae and Acetobacteraceae fami-
lies, Microbacterium, Lutibacterium, and Sphingomonas
genera, and Prevotella intermedia species (Table 2, S2 Fig).
3.4. Bile Acid Concentrations and O. felineus Infection. The
results of metabolomics analysis of O. felineus infection in
animal model show that urinary metabolic profiles of the
experimental animal change considerably and the urinary
BAs are among the main factors explaining the effect [24].
Thus, to investigate the role of the infection status on BA
composition in gallbladder disease, we analyzed the mea-
sured BAs with respect to the infection status of the patients.
There were no significant differences in BA level (Figure 3),
total gallbladder BA concentration (p = 0:24), and primary
to secondary BA ratio (p = 0:59) between O. felineus-infected
patients and control group.












Taurolithocholic acid (TLCA) 366.71 [362.42; 385.20]
Taurocholic acid (TCA) 221.61 [212.60; 233.91]
Cholic acid (CA) 36.67 [33.97; 41.39]
Deoxycholic acid (DCA) 33.47 [33.23; 33.90]
Ursodeoxycholic acid (UDCA) 7.87 [0; 8.37]
Chenodeoxycholic acid (CDCA) 1.27 [0.80; 1.83]
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4. Discussion
A functional interplay between BAs and microbial compo-
sition in gut is a well-documented phenomenon [25]. In
the bile, this phenomenon is far less studied, and with this
report, we describe the interactions between the BAs and
microbiota in this complex biological matrix. Collecting
the material for this study, we could not avoid inclusion
of the patients with O. felineus infection; thus, it is only
logical that we stress a possible influence of the infection
on BAs and bile microbiota community. The role of O.
felineus infection in the bile microbiota composition was
proposed and discussed by Saltykova et al. [7]. We have
shown that O. felineus infection has no strong effect on
the BA profile in patients with cholelithiasis. Yet, the
infection influences the gallbladder microbiota beta-
diversity.
Furthermore, we reported significant direct correlations
between TCA and TCDCA and the bile microbiota
alpha-diversity. TCA concentration was associated with
the appearance of species Jeotgalicoccus psychrophilus, Pre-
votella intermedia, and Haemophilus parainfluenzae in the
bile. TCDCA concentration shows positive associations
with the presence of OTUs belonging to Microbacterium,
Lutibacterium, and Sphingomonas genera and Prevotella
intermedia species.
In our study, we observed correlations between primary
BAs and bile bacteria, while fecal microbiota disturbance
was associated mostly with secondary BAs in feces. Specifi-
cally, the analysis of BAs and fecal microbiota in gallstone
patients revealed that genus Oscillospira was positively cor-
related with the fraction of secondary BAs; this association
is attributed to the association of Oscillospira and relative
fraction of lithocholic acid in the feces [26]. The positive
correlation between bacterial taxa and secondary BAs
was observed for patients with alcoholic cirrhosis and
severe alcoholic hepatitis [27]. It was hypothesized that
microbiota and secondary BA correlations were observed
due to the role of the gut flora in the direct or indirect
conversion of primary BAs to secondary BAs [28]. Here,
we observed correlations between primary BAs and bile
microbiota that may be related to different mechanisms
of the selective force of BAs for bile and gut microbiota.
It is worth of mentioning that TCA and TCDCA associ-
ated with bile microbiota diversity and composition are also
known as the markers of liver injury and/or liver dysfunction.
A recent report of Luo et al. indicates a possible role of TCA as





















bile acid concentrationsUnweighted UniFrac distance
Figure 1: Multidimensional scaling of CSS-corrected OTU abundances in unweighted UniFrac metric. Circle dots represent O. felineus-
infected samples; triangle dots represent control samples. Color intensity of dots represents the value of the first principal coordinate of
MDS-transformed metabolites.
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Figure 2: Correlations between alpha-diversity and bile acid concentrations. (a) In the plot, blue circles represent positive correlations, red
circles represent negative correlations, the size of circles and its color saturation represent absolute correlation value, and significant
correlations (FDR-corrected p value < 0.05) are marked with asterisk. (b) In the plot, black line represents regression curve for significant
associations, and gray zone represents standard error. CA: cholic acid; CDCA: chenodeoxycholic acid; DCA: deoxycholic acid; UDCA:
ursodeoxycholic acid; TCA: taurocholic acid; TCDCA: taurochenodeoxycholic acid; TLCA: taurolithocholic acid; GCA: glycocholic acid;
GCDCA: glycochenodeoxycholic acid; GDCA: glycodeoxycholic acid; Obs_otus: observed OTU index.
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Table 2: Associations between BA levels and microbial OTU abundances.
Bile acid Taxonomy Beta Standard error p value Adj. p value
TCA Actinomycetales 41.90 10.78 0.0006 0.0286
TCA Microbacterium 40.69 11.52 0.0015 0.0396
TCA Bacteroidales 84.87 22.18 0.0007 0.0286
TCA Prevotella intermedia 28.81 8.37 0.0019 0.0465
TCA Chitinophagaceae 54.63 9.89 7:51E − 006 0.0028
TCA Jeotgalicoccus psychrophilus 47.64 12.96 0.0010 0.0318
TCA 1-68 of (Tissierellaceae) 48.09 12.82 0.0009 0.0313
TCA Lutibacterium 46.67 12.15 0.0007 0.0286
TCA Lautropia 64.86 14.15 9:30E − 005 0.0114
TCA Haemophilus parainfluenzae 84.87 22.18 0.0007 0.0286
TCDCA Microbacterium 2114.47 550.69 0.0007 0.0286
TCDCA Prevotella intermedia 1548.85 393.14 0.0005 0.0286
TCDCA Chitinophagaceae 2608.39 501.50 1:77E − 005 0.0033
TCDCA Acetobacteraceae 2399.28 652.76 0.0010 0.0318
TCDCA Lutibacterium 2178.51 613.07 0.0014 0.0396
TCDCA Sphingomonas 1310.20 386.61 0.0022 0.0499










































































































































































































































































































































Figure 3: Concentrations of bile acids in gallbladder bile samples. On the plot boxes, patients with O. felineus infection (infected) and
patients without infection with O. felineus (noninfected) are represented. Whiskers’ length represents 1.5 of interquartile range. CA: cholic
acid; CDCA: chenodeoxycholic acid; DCA: deoxycholic acid; UDCA: ursodeoxycholic acid; TCA: taurocholic acid; TCDCA:
taurochenodeoxycholic acid; TLCA: taurolithocholic acid; GCA: glycocholic acid; GCDCA: glycochenodeoxycholic acid; GDCA:
glycodeoxycholic acid.
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demonstrated that TCA and TCDCA concentration was
elevated in serum of liver cirrhotic patients and positively cor-
related with Child–Pugh scores [29]. In vitro experiments
indicated that exposure to TCDCA increases expression
of the c-myc oncoprotein in WRL-68 cell (hepatocyte like
morphology) and downregulates expression CEBPα tumor
suppressor protein in HepG2 cells (epithelial morphology)
[30]. In a mouse model of hepatocellular carcinoma,
augmentation of TCDCA intestinal excretion prevented
carcinoma development [30].
Most of the bacteria associated with TCA and TCDCA
concentrations are treated as opportunistic pathogens.
Haemophilus parainfluenzae is a common liver pathogen.
It was found to be more abundant in fecal microbiome
of biliary cirrhosis patients [31] and was isolated from bile
samples of patients with acute cholecystitis [32] and liver
abscesses [33]. Microbacterium genus abundance was asso-
ciated with different inflammatory disorders: otitis externa
[34], noma [35], and bacteremia [36]. OTUs belonging to
(Tissierellaceae) family were more abundant in ulcerative
colitis sites [37]. Prevotella intermedia was identified in
atopic liver abscess and in case of periodontitis [38].
In conclusion, associations between diversity, taxonomic
profile of bile microbiota, and bile BA levels were evidenced
in patients with cholelithiasis. The increase of TCDCA and
TCA concentration correlates with bile microbiota alpha-
diversity and appearance of opportunistic pathogens in bile
of patients with cholelithiasis.
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